Geron Corporation (GERN) Stock Price, Quote, History ... Geron Corporation (GERN), a late-stage clinical development biopharmaceutical company, today announced an update to information from its March 12 year-end conference call related to the impact of the COVID-19 pandemic on the Company’s business, and described the measures being taken to protect the safety of Geron’s employees and patients in Geron Corp Stock Quote: GERN Stock News, Quotes, Analysis ... Nov 05, 2019 · GERN, Geron Corp - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines
Geron Corp : GERN Stock Price Quote at Ally Invest Geron Q4 Results Best Estimates, Sets Operating Expense Outlook - Stock Up 2% After-Hours 4:36PM ET 3/12/2020 MT Newswires. Geron (GERN) on Thursday widened its net loss to $0.15 per share in Q4 from $0.04 per share a year earlier, but still narrower than analysts' estimates of Geron Corporation (GERN) stock price, quote, history ...
Wall Street calls Geron (NASDAQ:GERN) a strong buy, so there is clearly a good deal of excitement about the stock, but also a good deal of risk. The question of whether to buy shares of the Geron stock price surge hinges on flimsy, selective ... Mar 27, 2018 · G eron (GERN), a small biotech developing an experimental treatment for myelofibrosis, is the top-performing stock in the sector this year. The reason is shaky. Shares of Geron have more than GERN - Geron Corp Stock Price History - Barchart.com The historical data and Price History for Geron Corp (GERN) with Intraday, Daily, Weekly, Monthly, and Quarterly data available for download.
What's Going On With Geron? (NASDAQ:GERN) | Benzinga Aug 25, 2018 · Geron Corporation (NASDAQ: GERN) stock is popping Friday without any major news from the company.Traders are speculating the huge jump in … GERN -- Is Its Stock Price A Worthy Investment? Learn More. GERN Stock Summary. With a price/sales ratio of 474.73, Geron Corp has a higher such ratio than 99.43% of stocks in our set. With a year-over-year growth in debt of 535.32%, Geron Corp's debt growth rate surpasses 95.73% of about US stocks. Geron: The Last Chapter - Geron Corporation (NASDAQ:GERN ... Sep 21, 2018 · Geron (NASDAQ:GERN) has one therapy, imetelstat, currently in clinical trials for treatment of two serious hematological cancers.The first trial is IMbark for Myelofibrosis (MF), the second is Is Geron Stock a Buy? | The Motley Fool
Geron Corp. (GERN) Stock Message Board - InvestorsHub Add GERN Price Alert Hide Sticky Hide Intro Moderator: Search This Board: 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003+